The drug enhances insulin secretion from pancreatic beta cells in a glucose-dependent manner, meaning it stimulates insulin release only when blood glucose levels are elevated
A qualitative study
Common requirements include documented BMI meeting the threshold, proof of previous weight loss attempts (usually 3-6 months of supervised diet and exercise), at least one qualifying comorbidity, and sometimes evidence that other treatments have been tried and failed
Cambios en la viscosidad : Si el lquido parece ms espeso, pegajoso o tiene una consistencia alterada
Higher body weight-dependent neural activation during reward processing
Adverse Reactions Adverse reactions commonly associated with Toujeo include hypoglycemia, hypersensitivity reactions, injection site reactions, lipodystrophy, pruritus, rash, edema, and weight gain